EMN Trial Office S.r.l. Impresa Sociale

Quick facts

Phase 2 pipeline

• Isatuximab-dexamethasone

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• EMN Trial Office S.r.l. Impresa Sociale portfolio CI brief
• EMN Trial Office S.r.l. Impresa Sociale pipeline updates RSS

Related

• Sector hub: All tracked pharma companies